ZeClinics - Powering Discovery with Zebrafish

Zebrafish-expert CRO tailoring solutions for understanding human disease and performing drug and target discovery.

ZeClinics expertise in CRISPR genome editing allows developing custom zebrafish genetic models to mimic human disease and addressing the biomedical relevance of candidate compounds and genes in vivo. Zebrafish bridges the gap between cell and rodent experimental models, enabling accelerated and cost-effective drug and target discovery.

Our zebrafish models are contributing to the successful research at:

Our team

ZeClinics makes you part of our scientific team from the start of your project. Our scientific experts accompany you throughout the design, execution and reporting, so you will feel confident when you present the data to your stakeholders.

Explore our services

Zebrafish experimental advantages – number of individuals, small size, transparency – allow us to test the effect of several drugs and dosages in parallel: on specific tissues and the whole animal. Zebrafish shares high genomic and physiological conservation with humans, displaying analogous organs, cell types and biological processes. In short, the use of zebrafish will accelerate your research, while providing great translatability on how your candidate gene or molecule might impact human biology.

ZeClinics is focused on the zebrafish model because reducing the use of animals in experimentation is important for you, your company, society…and for us!

Proudly supported by:

If you are involved in biomedical and chemical research you can benefit from ZeClinics expertise in zebrafish. LEARN MORE

SCIENCE |

Toward the Use of Novel Alternative Methods in Epilepsy Modeling and Drug Discovery

We explore animal alternatives, particularly zebrafish larval models, along with advanced Crispr/Cas9 techniques, streamlining epilepsy modeling and antiepileptic drug trials.


VIEW ALL SCIENCE

NEWS |

ZeClinics, Celtarys Research, and the University of Santiago come together to develop new drugs for Parkinson’s treatment

The project combines ZeClinics' in vivo drug screening, Celtarys' fluorescent tools, and USC-Biofarma's in vitro screening expertise.


VIEW ALL NEWS

BLOG |

The future of animal testing 


BLOG |

CRISPR: the genetic scissors


VIEW ALL BLOG

Guarantee your research results with a reliable ethical alternative. We challenge traditional drug discovery by thinking differently.  Let us help you carry out innovative research. GET IN CONTACT